Exercise Echocardiography Registry for Ischemic and Non-Ischemic Heart Disease
Run by Yonsei University · NCT07367893 · Data updated 2026-11-12
This registry tests how exercise echocardiography findings relate to heart disease in adults with ischemic or non-ischemic conditions during routine care.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 10000 (estimated) |
| Sponsor | Yonsei University Academic / other |
| Locations | 1 site (Yongin, Gyeonggi-do) |
| Status | Recruiting |
| Started | April 1, 2026 |
| Main results expected | December 31, 2030 |
| Study ends | December 31, 2035 |
| Registry record updated | May 22, 2026 |
| Trial ID | NCT07367893 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults 18 years or older referred for clinically indicated exercise echocardiography to evaluate ischemic or non-ischemic heart disease or related exercise symptoms.
✕Probably not a fit
Patients unable to perform exercise testing or with non-interpretable imaging, or those not expected to benefit from insights derived from this registry, may not gain direct individual benefits.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a prospective, observational registry collecting standardized clinical, exercise, and echocardiographic data from adults undergoing clinically indicated exercise echocardiography at a tertiary care center. It includes patients with suspected or established ischemic heart disease as well as non-ischemic conditions such as cardiomyopathy, heart failure, and valvular disease. The goal is to describe how exercise-induced changes in heart structure and function relate to clinical outcomes in real-world practice. No extra diagnostic procedures are required beyond standard care. Data will be used to better understand prognostic implications of exercise echocardiography across diverse heart diseases.
Why it matters
Potential benefit: If successful, the registry could improve understanding of prognostic indicators from exercise echocardiography and inform clinical decision-making for both ischemic and non-ischemic heart disease.
How similar studies have gone: Prospective exercise echocardiography data have informed practice in ischemic disease; however, real-world, cross-disease registries spanning both ischemic and non-ischemic conditions are less common and ask new questions.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adults aged 18 years or older * Patients referred for clinically indicated exercise echocardiography as part of routine clinical care * Patients evaluated for suspected or known ischemic heart disease, or non-ischemic heart disease, including but not limited to: Cardiomyopathy, Heart failure, Valvular heart disease, Structural heart disease * Ability to perform exercise-based stress testing using treadmill or bicycle protocols * Availability of baseline clinical data and interpretable echocardiographic images obtained during rest and exercise * Provision of informed consent, or eligibility for consent waiver in accordance with institutional review board approval Exclusion Criteria: * Inability to perform exercise testing due to non-cardiac limitations, such as severe orthopedic, neurologic, or pulmonary conditions * Poor echocardiographic image quality that does not allow meaningful interpretation of exercise-induced changes * Any condition deemed by the treating physician to make participation inappropriate or unsafe, even within an observational framework
Where it's running
-
Yonsei University Yongin Severance Hospital
Yongin, Gyeonggi-do, South Korea Recruiting
Study contacts
- Study coordinator: SungA Bae, MD., PhD.
- Email: cardiobsa@yuhs.ac
- Phone: +821023273578
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Patient-specific MRD liquid biopsy for resected NSCLC
This study tests a personalized MRD blood and bronchial washing test after surgery to see if it can signal recurrence earlier in people with resected NSCLC.
-
Autologous adipose-derived stem cell injections for knee osteoarthritis
We’re testing whether injecting a patient’s own fat-derived stem cells into the knee can help people with knee OA feel less pain and move better, compared with a standard hyaluronic acid treatment.
-
SVF cellular mix, secretome, and knee response in osteoarthritis
This study tests the cellular composition and secretome of research-only adipose-derived SVF in adults with knee OA who are already planned to receive an autologous SVF injection as part of their care.
-
2-mm subchondral drilling vs sequential 4-mm and 2-mm drilling during CARTISTEM implantation for knee cartilage defects
This study tests whether drilling the knee with a 2-mm drill alone works as well as sequential 4-mm then 2-mm drilling when combined with CARTISTEM treatment for medial knee cartilage defects.
-
Blood biomarker cohort for memory disorders in older adults
This observational cohort will collect blood samples and brain imaging data from adults 50+ with memory disorders and a small group of healthy young adults to help find biomarkers.
-
Difference in finger, earlobe, and forehead oxygen levels to predict outcomes in dyspnea
In adults with breathing trouble, this study tests whether differences in SpO2 readings from different body sites can predict who might have worse outcomes.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.